QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：中南大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival 期刊论文 Oncogene, 2018, 卷号: 37, 期号: 29, 页码: 3937-3952 作者:  Liu, J. Y.;  Zeng, Q. H.;  Cao, P. G.;  Xie, D.;  Yang, F. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 期刊论文 The Lancet, 2015, 卷号: 386, 期号: 10010, 页码: 2287-2323 作者:  Forouzanfar, Mohammad H.;  Alexander, Lily;  Anderson, H. Ross;  Bachman, Victoria F.;  Biryukov, Stan 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/03 Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma 期刊论文 Annals of Oncology, 2015, 卷号: 26, 期号: 8, 页码: 1766-1771 作者:  Shi, Y.*;  Dong, M.;  Hong, X.;  Zhang, W.;  Feng, J. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03 angioimmunoblastic lymphadenopathy  histology  leukopenia  neutropenia  phase 2 clinical trials  thrombocytopenia   Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy 期刊论文 Oncogene, 2014, 卷号: 33, 期号: 37, 页码: 4568-4578 作者:  Xiao, L.;  Hu, Z-Y;  Dong, X.;  Tan, Z.;  Li, W. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03 Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients 期刊论文 Annals of Oncology, 2013, 卷号: 24, 期号: 7, 页码: 1786-1792 作者:  Y. Zhao;  W. J. Wang;  S. Guan;  H. L. Li;  R. C. Xu 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03 advanced adult primary liver cancer  child-turcotte-pugh classification  combined modality therapy  eastern cooperative oncology group  sorafenib